Log In
Print this Print this

S47445 (formerly CX1632)

  Manage Alerts
Collapse Summary General Information
Company RespireRx Pharmaceuticals Inc.
DescriptionAmpakine enhancer of the AMPA glutamate receptor
Molecular Target AMPA glutamate receptor (GRIA) (GLUR)
Mechanism of ActionAMPA receptor enhancer
Therapeutic ModalitySmall molecule
Latest Stage of DevelopmentPhase II
Standard IndicationAlzheimer's disease (AD)
Indication DetailsTreat Alzheimer's disease (AD)
Regulatory Designation

 Product Details
 Archive Items are loading loading
Collapse Summary Deals Information
 Deals Details
Get a free BioCentury trial today